<DOC>
	<DOCNO>NCT01407848</DOCNO>
	<brief_summary>In study prospectively analyze benefit inhale furosemide preterm term neonate Transient Tachypnoea .</brief_summary>
	<brief_title>Trial Treatment With Inhaled Furosemide Preterm Term Neonates With Transient Tachypnoea</brief_title>
	<detailed_description>In study prospectively analyze benefit inhale furosemide preterm term neonate transient Tachypnoea . Patients receive nebulised Furosemide iv solution 1 mg/kg nebulised 0,9 % saline ( 4x/d ) blind condition random order long need CPAP-treatment max . 3 day . 20 Patient treating . The benefit measure reduction dyspnea , respiratory rate , oxygen demand time CPAP .</detailed_description>
	<mesh_term>Transient Tachypnea Newborn</mesh_term>
	<mesh_term>Tachypnea</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<criteria>Neonates 35+039+0 GA first day life clinical diagnosis Transient Tachypnoea The need CPAP &gt; 6 h obtain oxygen saturation &gt; 92 % Written inform consent parent/guardian Systemic infection Intubation mechanical ventilation Inclusion trail Malformation several disease disturb respiratory Subjects participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>